UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Correction to: p14ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Oncogene, 2021-05, Vol.40 (20), p.3633-3634

2021

Volltextzugriff (PDF)

Nuclear trafficking of EGFR by Vps34 represses Arf expression to promote lung tumor cell survival

Oncogene, 2016-07, Vol.35 (30), p.3986-3994

2016

Volltextzugriff (PDF)

p14(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Oncogene, 2013-02, Vol.32 (8), p.1050

2013

Volltextzugriff (PDF)

Progastrin, a new blood biomarker for the diagnostic and therapeutic monitoring, in gastro-intestinal cancers: A BIG-RENAPE project

Annals of oncology, 2018-10, Vol.29, p.viii37-viii37

2018

Volltextzugriff (PDF)

Développement et validation d’un questionnaire d’évaluation de la Qualité de Vie Alimentaire (QVA) chez les patients atteints de cancer

Nutrition clinique et métabolisme, 2022-02, Vol.36 (1), p.S54-S55

2022

Volltextzugriff (PDF)

496: Nuclear EGFR controls the expression of the ARF tumor suppressor

European journal of cancer (1990), 2014-07, Vol.50, p.S119-S119

2014

Volltextzugriff (PDF)

321 An EGFR/ARF Cross-talk Controls the Growth of Lung Adenocarcinoma Cells With Mutant EGFR

European journal of cancer (1990), 2012-07, Vol.48, p.S78-S79

2012

Volltextzugriff (PDF)

Correction to: p14.sup.ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Oncogene, 2021-05, Vol.40 (20), p.3633

2021

Volltextzugriff (PDF)

614P Tolerance and preliminary efficacy of intraperitoneal (IP) nivolumab after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with advanced ovarian carcinoma: A phase I study with expansion cohort (ICONIC)

Annals of oncology, 2022-09, Vol.33, p.S825

2022

Volltextzugriff (PDF)

Feasibility of a screening and prevention procedure for risks associated with dysphagia in older patients in geriatric units: the DYSPHAGING pilot study protocol

BMJ open, 2024-04, Vol.14 (4), p.e081333-e081333

2024

Volltextzugriff (PDF)

Correction to: p14 ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Oncogene, 2021-05, Vol.40 (20), p.3633

2021

Volltextzugriff (PDF)

A modification of cAMP compartmentation is involved in the doxorubicin-induced cardiotoxicity

Archives of Cardiovascular Diseases Supplements, 2021-05, Vol.13 (2), p.210-210

2021

Volltextzugriff (PDF)

p14 super(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Oncogene, 2013-02, Vol.32 (8), p.1050-1058

2013

Volltextzugriff (PDF)

p14.sup.ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Oncogene, 2013-02, Vol.32 (8), p.1050

2013

Volltextzugriff (PDF)

inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Oncogene, 2013-02, Vol.32 (8), p.1050

2013

Volltextzugriff (PDF)

p14ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Oncogene, 2013-02, Vol.32 (8), p.1050-1058

2013

Volltextzugriff (PDF)

Impact of a food enhancement strategy on food appreciation in cancer patients undergoing chemotherapy treatment

Clinical nutrition ESPEN, 2023-12, Vol.58, p.618-618

2023

Volltextzugriff (PDF)

119PProgastrin, a new blood biomarker for the diagnostic and therapeutic monitoring, in gastro-intestinal cancers: A BIG-RENAPE project

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

468 Role of the p14ARF tumour suppressor in EGFR-mediated growth control of lung cancer cells

European journal of cancer supplements, 2010, Vol.8 (5), p.120-120

2010

Volltextzugriff (PDF)

Risk factors associated with day-30 mortality in patients over 60 years old admitted in ICU for severe COVID-19: the Senior-COVID-Rea Multicentre Survey protocol

BMJ open, 2021, Vol.11 (7)

2021

Volltextzugriff (PDF)

Contrôle de la protéine suppressive de tumeur p14ARF par le récepteur à l’EGF : contribution à la carcinogenèse bronchique et à la réponse aux TKIs

Revue des maladies respiratoires, 2012-01, Vol.29, p.A11-A12

2012

Volltextzugriff (PDF)

Contrôle de la protéine suppressive de tumeur p14 ARF par le récepteur à l’EGF : contribution à la carcinogenèse bronchique et à la réponse aux TKIs

Revue des maladies respiratoires, 2012, Vol.29, p.A11-A12

2012

Volltextzugriff (PDF)

Hybrid gadolinium oxide nanoparticles combining imaging and therapy

Journal of materials chemistry, 2009, Vol.19 (16), p.2328-2335

2009

Volltextzugriff (PDF)

Hybrid gadolinium oxide nanoparticles combining imaging and therapy

Journal of materials chemistry, 2009-04, Vol.19 (16), p.2328-2335

2009

Volltextzugriff (PDF)

Effects of low doses of gamma-radiation on the development of cardiac pathologies and heart rhythm disorders in male C57Bl/6J mice

Archives of cardiovascular diseases supplements, 2023-05, Vol.15 (2), p.227

2023

Volltextzugriff (PDF)

1 – 25 von 350

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(279)
Mit Volltextzugriff
(276)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Correction to: p14ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Nuclear trafficking of EGFR by Vps34 represses Arf expression to promote lung tumor cell survival

p14(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Progastrin, a new blood biomarker for the diagnostic and therapeutic monitoring, in gastro-intestinal cancers: A BIG-RENAPE project

Développement et validation d’un questionnaire d’évaluation de la Qualité de Vie Alimentaire (QVA) chez les patients atteints de cancer

496: Nuclear EGFR controls the expression of the ARF tumor suppressor

321 An EGFR/ARF Cross-talk Controls the Growth of Lung Adenocarcinoma Cells With Mutant EGFR

Correction to: p14.sup.ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

614P Tolerance and preliminary efficacy of intraperitoneal (IP) nivolumab after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with advanced ovarian carcinoma: A phase I study with expansion cohort (ICONIC)

Feasibility of a screening and prevention procedure for risks associated with dysphagia in older patients in geriatric units: the DYSPHAGING pilot study protocol

Correction to: p14 ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

A modification of cAMP compartmentation is involved in the doxorubicin-induced cardiotoxicity

p14 super(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

p14.sup.ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

p14ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

Impact of a food enhancement strategy on food appreciation in cancer patients undergoing chemotherapy treatment

119PProgastrin, a new blood biomarker for the diagnostic and therapeutic monitoring, in gastro-intestinal cancers: A BIG-RENAPE project

468 Role of the p14ARF tumour suppressor in EGFR-mediated growth control of lung cancer cells

Risk factors associated with day-30 mortality in patients over 60 years old admitted in ICU for severe COVID-19: the Senior-COVID-Rea Multicentre Survey protocol

Contrôle de la protéine suppressive de tumeur p14ARF par le récepteur à l’EGF : contribution à la carcinogenèse bronchique et à la réponse aux TKIs

Contrôle de la protéine suppressive de tumeur p14 ARF par le récepteur à l’EGF : contribution à la carcinogenèse bronchique et à la réponse aux TKIs

Hybrid gadolinium oxide nanoparticles combining imaging and therapy

Hybrid gadolinium oxide nanoparticles combining imaging and therapy

Effects of low doses of gamma-radiation on the development of cardiac pathologies and heart rhythm disorders in male C57Bl/6J mice

Suchergebnisse filtern